Rite Aid 2013 Annual Report Download - page 68

Download and view the complete annual report

Please find page 68 of the 2013 Rite Aid annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 125

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125

RITE AID CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Years Ended March 2, 2013, March 3, 2012 and February 26, 2011
(In thousands, except per share amounts)
1. Summary of Significant Accounting Policies
Description of Business
The Company is a Delaware corporation and through its 100 percent owned subsidiaries, operates
retail drugstores in the United States of America. It is one of the largest retail drugstore chains in the
United States, with 4,623 stores in operation as of March 2, 2013. The Company’s drugstores’ primary
business is pharmacy services. The Company also sells a full selection of health and beauty aids and
personal care products, seasonal merchandise and a large private brand product line.
The Company’s operations consist solely of the retail drug segment. Revenues are as follows:
Year Ended
March 2, March 3, February 26,
2013 2012 2011
(52 Weeks) (53 Weeks) (52 Weeks)
Pharmacy sales .................... $17,083,811 $17,725,645 $17,036,027
Front end sales .................... 8,200,022 8,293,643 8,081,576
Other revenue ..................... 108,430 101,934 97,304
$25,392,263 $26,121,222 $25,214,907
Sales of prescription drugs represented approximately 67.6%, 68.1%, and 67.8% of the Company’s
total sales in fiscal years 2013, 2012 and 2011, respectively. The Company’s principal classes of products
in fiscal 2013 were the following:
Percentage
Product Class of Sales
Prescription drugs ......................................... 67.6%
Over-the-counter medications and personal care ................... 9.9%
Health and beauty aids ..................................... 5.2%
General merchandise and other ............................... 17.3%
Fiscal Year
The Company’s fiscal year ends on the Saturday closest to February 29 or March 1. The fiscal year
ended March 2, 2013 included 52 weeks. The fiscal year ended March 3, 2012 included 53 weeks and
the fiscal year ended February 26, 2011 included 52 weeks.
Principles of Consolidation
The consolidated financial statements include the accounts of the Company and all of its
100 percent owned subsidiaries. All significant intercompany accounts and transactions have been
eliminated in consolidation.
67